Title: Why are most phospholipidosis inducers also hERG blockers?
Journal: Archives of toxicology 20171201
Title: Side chain flexibilities in the human ether-a-go-go related gene potassium channel (hERG) together with matched-pair binding studies suggest a new binding mode for channel blockers.
Journal: Journal of medicinal chemistry 20090723
Title: Ordering and disordering of molecular solids upon mechanical milling: the case of fananserine.
Journal: Journal of pharmaceutical sciences 20081101
Title: Molecular mobility in glass forming fananserine: a dielectric, NMR, and TMDSC investigation.
Journal: Pharmaceutical research 20060401
Title: N-[(3S)-1-benzylpyrrolidin-3-yl]-(2-thienyl)benzamides: human dopamine D4 ligands with high affinity for the 5-HT2A receptor.
Journal: Bioorganic & medicinal chemistry letters 20051201
Title: [Thermodynamics of drug polymorphism: domains and stability hierarchy by pressure temperature diagram. Application to the tetramorphism of fananserine].
Journal: Annales pharmaceutiques francaises 20020501
Title: 4-(Phenylsulfonyl)piperidines: novel, selective, and bioavailable 5-HT(2A) receptor antagonists.
Journal: Journal of medicinal chemistry 20020117
Title: Current and novel approaches to the drug treatment of schizophrenia.
Journal: Journal of medicinal chemistry 20010215
Title: Autoradiographic studies of RP 62203, a potent 5-HT2 receptor antagonist. Pharmacological characterization of [3H]RP 62203 binding in the rat brain.
Journal: European journal of pharmacology 19930316
Title: Heuillet E, et al. The naphtosultam derivative RP 62203 (fananserin) has high affinity for the dopamine D4 receptor. Eur J Pharmacol. 1996 Oct 24;314(1-2):229-33.
Title: Malgouris C, et al. Autoradiographic studies of RP 62203, a potent 5-HT2 receptor antagonist. In vitro and ex vivo selectivity profile. Eur J Pharmacol. 1993 Mar 16;233(1):29-35.
Title: Stutzmann JM, et al. RP 62203, a 5-hydroxytryptamine2 antagonist, enhances deep NREM sleep in rats. Sleep. 1992 Apr;15(2):119-24.